JordanGellerMD

PubMed

• 26 citations
  Increase in bone mass after correction of vitamin D insufficiency in bisphosphonate-treated patients.
  Jordan L. Geller, Bei Hu, S. Reed, James Mirocha, John S. Adams
  Endocrine Practice. 2008-05-07
• 22 citations
  Vitamin D–Mediated Hypercalcemia in Slack Skin Disease: Evidence for Involvement of Extrarenal 25-Hydroxyvitamin D 1α-Hydroxylase†
  Helen Karakelides, Jordan L. Geller, Arnold L. Schroeter, Hong Chen, Philip S Behn
  Journal of Bone and Mineral Research. 2006-09-01
• 61 citations
  Treatment with infliximab is associated with increased markers of bone formation in patients with Crohn's disease.
  Maria T. Abreu, Jordan L. Geller, Eric A. Vasiliauskas, Lori Y. Kam, Puja Vora
  Journal of Clinical Gastroenterology. 2006-01-01

Books/Book Chapters

• Clinical Science Color Atlas 
  Bhushan V, Pall V, Le T, Yen YM, Geller JL, Gupta SBlackwell2002

Abstracts/Posters

• Vitamin D Insufficiency and Unresponsiveness to Bisphosphonates
  Geller JL, Reed, S, Mirocha J, Adams JS, Cleveland Clinic Bone Innovation Summit, 5/5/2006
• Cinacalcet Is Associated with Decreased Serum FGF-23 and Improved Phosphorous Homeostasis in Patients with Tumor-Induced Osteomalacia
  JL. Geller, C. Cutler, M. H. Kelly, J. S. Adams, M. T. Collins, The 27th Annual Meeting of the American Society for Bone and Mineral Research, Nashville, TN, 1/1/2005
• Vitamin D- Mediated Hypercalcemia in Granulomatous Slack Skin Disease: Evidence for the Extra- renal 1-Hydroxylation of 25-hydroxvitamin D in Involved Skin Granulomata
  Wermers RA, Karakelides H, Adams JS, Chen H, Geller JL, Hewison M, Endocrine Society 87th Annual Meeting, San Diego, CA, 1/1/2005
• Recurrent and Metastatic Pigmented Adrenocortical Carcinoma
  Geller JL, Azer P, Mertens, RB, Weiss LM, Endocrine Society 87th Annual Meeting, San Diego, CA, 1/1/2005
• Treatment with Infliximab is Associated With Increased Markers of Bone Formation in Patients With Crohn's Disease
  Abreu MT, Kam LY, Vasiliauskas EA, Vora P, Adams JS, Yang H, Geller JL, et al, American Society for Bone and Mineral Research, 26th Annual Meeting, Seattle, WA, 1/1/2004
• Join now to see all

Lectures

• Identification and Treatment of Secondary Causes of Osteoporosis 
  10/5/2013
• Hypothyroidism and the Importance of Patient-Physician Dialogue 
  4/17/2013
• Management of Autoimmune Thyroid Disease in Patients Undergoing IVF 
  6/13/2011
• The Conundrum of Normocalcemic Hyperparathyroidism 
  3/24/2011
• The Spectrum of Primary Hyperparathyroidism 
  3/11/2011
• Key Concepts in Bone Mineral Densitometry 
  2/28/2009
• Osteoporosis: Not Just Your Grandmother’s Disease 
  1/29/2009
• Osteoporosis Myths 
  11/11/2008
• Common Endocrine Issues in the Hospitalized Patient 
  4/5/2008
• Exploiting the Calcium-Sensing Receptor in the Management of Hypophosphatemic Osteomalacia 
  11/7/2007
• The Top 10 Vitamin D Myths 
  9/28/2007
• A Fast Acting Goiter 
  6/28/2007
• Osteoporosis Myths, Legends, Rumors and Lies 
  6/1/2007
• Vitamin D Dysregulation 
  1/11/2007
• Gonadotropin Secreting Pituitary Adenoma with Ovarian Hyperstimulation 
  11/28/2006
• American Board of Internal Medicine Endocrinology Review 
  6/19/2006
• The Association of Vitamin D Insufficiency with a Declining Response to Bisphosphonates 
  5/4/2006
• Principles of Bone Densitometry 
  5/1/2006
• Familial Nonmedullary Thyroid Carcinoma 
  1/26/2006
• Metastatic Pheochromocytoma: Management 
  11/15/2005
• Cinacalcet in the Management of FGF-23-Mediated Hypophosphatemia 
  9/26/2005
• Metastatic Pheochromocytoma: Clinical Presentation 
  7/21/2005
• What is “Off-Label?” 
  6/14/2005
• A Case of an Invasive Prolactinoma 
  3/29/2005
• Prolactinoma within a Rathke’s Cleft Cyst Invading Bone 
  2/1/2005
• Join now to see all